- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01513980
Life-long Monitoring of COPD in Veneto Region
RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring in COPD
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Padova, Italy, 35127
- Local Health Autority n.16 Padova - Pulmonology outpatient clinic
-
Padova, Italy, 35128
- Hospital Trust of Padova - Respiratory Physiopathology Department
-
Treviso, Italy, 31100
- Ospedale Ca'Foncello - Pulmonology Department
-
Verona, Italy, 37124
- Hospital Trust of Verona - Pneumonology Department
-
-
Venezia
-
Mestre, Venezia, Italy, 30174
- Ospedale dell'Angelo - Pulmonology Department
-
-
Verona
-
Marzana, Verona, Italy, 37034
- Ospedale di Marzana - Rehabilitative respiratory unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 18 years.
- COPD GOLD class 3-4
- Life expectance > 12 months
Exclusion Criteria:
• Patient unable to use the equipment provided (alone or assisted).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Treatment as usual
|
|
Experimental: Self monitoring for patients with COPD
Procedure: self-monitoring for patients with severe COPD
|
Patients are equipped with a telemonitoring kit composed by a portable wrist-clinic device for clinical parameters measuring and a gateway device for data transmission. The patient can monitor pulse-oxymetry and heart rate with a frequency set by the clinician in the personalised treatment plan. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alert the reference clinician in case of worsening of symptoms. CAT questionnaire is monthly administrated by phone to the patients |
Experimental: Nurse monitoring for patients with COPD
Procedure: nurse-monitoring for patients with severe COPD
|
A nurse is in charge of data collection during home visits with a frequency set by the lung specialist depending to the patient clinical conditions.
The nurse uses portable biomedical devices to measure pulse-oxymetry, heart rate, spirometry and if scheduled an arterial blood gas test.
Data are transmitted to the clinician who checks them on his laptop in the hospital and completes the visit with the medical report.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health-Related quality of life
Time Frame: 12 months
|
Health-Related Quality of Life is assessed by the SF-36 questionnaire
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cause mortality
Time Frame: 12 months
|
12 months
|
|
Number of specialist visits
Time Frame: 12 months
|
12 months
|
|
Number of re-hospitalizations
Time Frame: 12 months
|
12 months
|
|
Number of visits to emergency department
Time Frame: 12 months
|
12 months
|
|
Number of bed days for hospitalised patients
Time Frame: 12 months
|
12 months
|
|
Anxiety and depression status
Time Frame: 12 months
|
Anxiety and depression status is assessed by Hospital Anxiety and Depression Scale, (HADS).
|
12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Massimo Fusello, MD, Local Health authority Veneziana
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- G. A. 250487-Veneto WP8Cl5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease, Chronic Obstructive
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on self-monitoring for patients with severe COPD
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedPulmonary Disease, Chronic Obstructive (COPD)Austria
-
Regione VenetoEuropean Commission; Azienda ULSS 4 Alto VicentinoCompleted
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedDiabetes Mellitus Type 2Austria
-
Duke UniversityMedtronicCompletedVentricular Fibrillation | Tachycardia, VentricularUnited States
-
Shenzhen Second People's HospitalNot yet recruiting
-
University of Santa Cruz do SulUnknownChronic Obstructive Pulmonary DiseaseBrazil
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); Duke UniversityActive, not recruiting
-
Northwell HealthNational Institute on Aging (NIA)Not yet recruitingType 2 DiabetesUnited States
-
Jens Rikardt AndersenCompleted
-
Diakonhjemmet HospitalRecruiting